Preview complete
The prescreener preview is complete. You may now close the preview.
Adults With or Without Chronic Kidney Disease Needed for CBD Study
M
Michael Eadon, MD
Primary Investigator
Recruiting
18-75 years
All
Phase
1
72 participants needed
2 Locations
Brief description of study
Have you ever wondered about the safety of medicinal CBD? Join our study!
What is this study about?
The goal of this study is to assess the safety of CBD with tacrolimus, an agent taken by transplant patients to prevent organ rejection. This study seeks to understand the interaction between CBD and tacrolimus along with the underlying genetic factor.
Who can participate?
Adults, 18-65 years of age, with or without chronic kidney disease
Detailed description of study
What happens during study participation?
- Attend 3 separate 12hr inpatient visits
- Attend 6 brief outpatient visits
- All visits will be at IU University Hospital in Indianapolis, IN
Incentive/compensation
- $50 for the screening visit and $1000 for completion of all visits
- Parking validation for all visits
Additional information
Study title: Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
To learn more about PI Michael T. Eadon, MD and his research interests, please visit this link: https://medicine.iu.edu/faculty/5161/eadon-michael
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Healthy, Kidney Disease
-
Age: Between 18 Years - 75 Years
-
Gender: All
Inclusion Criteria:
- Generally healthy or have kidney disease
- BMI 18.5-35
Not used tobacco or marijuana in the past 3 months
Updated on
04 Nov 2024.
Study ID: CPHR-IIR-DRUG-GENE, 12763
Pre-Screener
